WI-38

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
WI-38 cells (Left: in high density. Right: in low density).

WI-38 is a diploid human cell strain composed of fibroblasts derived from lung tissue of a 3-months gestation female fetus.[1][2] The cell strain, isolated by Leonard Hayflick in the 1960s,[3] has been used extensively in scientific research, with applications ranging from developing important theories in molecular biology and aging to the production of most human virus vaccines.[4] The contributions from this cell strain towards human virus vaccine production have been credited with avoiding disease in, or saving the lives of, billions of people.[5][6]

History[edit]

The WI-38 cell strain stemmed from earlier work by Hayflick growing human cell cultures.

In the early 1960's, Hayflick and his colleague Paul Moorhead at the Wistar Institute in Philadelphia, Pennsylvania discovered that when normal human cells were stored in a freezer, the cells remembered the doubling level at which they were stored and, when reconstituted, began to divide from that level to roughly 50 total doublings (for cells derived from fetal tissue). Hayflick determined that normal cells gradually experience signs of senescence as they divide, first slowing before stopping division altogether.[2][3] This finding is the basis for the Hayflick limit, which specifies the number of times a normal human cell population will divide before cell division stops.[7] Hayflick's discovery later contributed to the determination of the biological roles of telomeres.[8] Hayflick claimed that the finite capacity of normal human cells to replicate was an expression of aging or senescence at the cellular level.[2][3][7]

During this period of research, Hayflick also discovered that if cells were properly stored in a freezer, cells would remain viable and that an enormous number of cells could be produced from a single starting culture. One of the cell strains that Hayflick isolated, which he named WI-38, was found to be free of contaminating viruses, unlike the primary monkey kidney cells then in use for virus vaccine production.[3] In addition, WI-38 cells could be frozen, then thawed and exhaustively tested. These advantages led to WI-38 quickly replacing primary monkey kidney cells for human virus vaccine production.[5][6][9] WI-38 has also been used for research on numerous aspects of normal human cell biology.[6][7][9]

Applications[edit]

WI-38 was invaluable to early researchers, especially those studying virology and immunology, since it was a readily-available cell strain of normal human tissue. Unlike the HeLa cell line, which were cancerous cells, WI-38 was a normal human cell population. Researchers in labs across the globe have since used WI-38 in their discoveries, most notably Hayflick in his development of human virus vaccines.[5] Infected WI-38 cells secrete the virus, and can be cultured in large volumes suitable for commercial production.

Virus vaccines produced in WI-38 have prevented disease or saved the lives of billions of people.[5][6] Vaccines produced in WI-38 include those made against adenoviruses, rubella, measles, mumps, varicella zoster, poliovirus, hepatitis A and rabies.[4][5][6][9]

See also[edit]

References[edit]

  1. ^ "WI-38 (ATCC® CCL-75™)". 
  2. ^ a b c Hayflick, L; Moorhead PS (December 1961). "The serial cultivation of human diploid cell strains". Experimental Cell Research. 25 (3): 585–621. doi:10.1016/0014-4827(61)90192-6. PMID 13905658. 
  3. ^ a b c d Hayflick, L (March 1965). "The Limited in vitro Lifetime of Human Diploid Cell Strains". Experimental Cell Research. 37 (3): 614–636. doi:10.1016/0014-4827(65)90211-9. PMID 14315085. 
  4. ^ a b Fletcher, MA; Hessel, L; Plotkin, SA (1998). "Human diploid cell strains (HDCS) viral vaccines". Developments in Biological Standardization. 93: 97–107. PMID 9737384. 
  5. ^ a b c d e Olshansky, S.J.; Hayflick, L (2 March 2017). "The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity". AIMS Public Health. 4 (2): 127–138. doi:10.3934/publichealth.2017.2.127. 
  6. ^ a b c d e Wadman, M (26 June 2013). "Medical research: Cell division". Nature. 498 (7445): 422–426. doi:10.1038/498422a. 
  7. ^ a b c Shay JW, Wright WE; Wright (2000). "Hayflick, his limit, and cellular ageing" (PDF). Nature Reviews Molecular Cell Biology. 1 (1): 72–76. doi:10.1038/35036093. PMID 11413492. Archived from the original on 2010-07-13. 
  8. ^ Holliday, R (2012). "Telomeres and telomerase: the commitment theory of cellular ageing revisited". Science Progress. 95 (Pt 2): 199–205. PMID 22893980. 
  9. ^ a b c Hayflick, L. "Errors in the "Vaccine Race" Book" (PDF). 

External links[edit]